{"protocolSection":{"identificationModule":{"nctId":"NCT04352296","orgStudyIdInfo":{"id":"BMR_2020_12"},"organization":{"fullName":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"},"briefTitle":"Effect of Individualized Versus Standard Bp Management During MT for Anterior Ischemic Stroke","officialTitle":"Effect of Individualized Versus Standard Blood Pressure Management During Mechanical Thrombectomy for Anterior Ischemic Stroke","acronym":"DETERMINE"},"statusModule":{"statusVerifiedDate":"2023-09","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-03-08","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-09-18","type":"ACTUAL"},"completionDateStruct":{"date":"2024-11-20","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-04-10","studyFirstSubmitQcDate":"2020-04-15","studyFirstPostDateStruct":{"date":"2020-04-20","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-09-22","lastUpdatePostDateStruct":{"date":"2023-09-25","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"},"collaborators":[{"name":"Ministry of Health, France","class":"OTHER_GOV"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"DETERMINE is a multicenter, prospective, randomised, open, blinded end-point assessed (PROBE) trial, to evaluate two approaches of blood pressure (BP) management during mechanical thrombectomy for acute ischemic stroke due to an anterior large vessel occlusion.","detailedDescription":"This study have to objective to evaluate the efficacy of an individualized BP control during mechanical thrombectomy (regardless of the sedation modality), by maintaining a mean arterial pressure (MAP) within 10% of the first MAP measured in the angiography suit, compared to the standard BP management, on the 3-month functional outcome."},"conditionsModule":{"conditions":["Acute Cerebrovascular Accident"],"keywords":["Acute ischemic stroke","Large vessel occlusion","Mechanical thrombectomy","Blood pressure management","Brain infarction","Endovascular procedure","Thrombectomy","Blood pressure","Low blood pressure","Hemodynamic","Hypertension"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"OTHER","maskingInfo":{"masking":"SINGLE","whoMasked":["PARTICIPANT"]}},"enrollmentInfo":{"count":432,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Experimental group","type":"EXPERIMENTAL","description":"Individualized BP management during mechanical thrombectomy with the administration of diluted norepinephrine (5-10 µg/ml) or nicardipine (1 mg/ml) or urpidil (5 mg/ml) to maintain the MAP within 10% of the first MAP measured in the angiography suit.","interventionNames":["Procedure: Individualized blood pressure"]},{"label":"Control group","type":"ACTIVE_COMPARATOR","description":"Standard BP management based on international guidelines: Treatment of hypotension defined by a systolic blood pressure \\<140 mm Hg, and treatment of hypertension defined by a systolic blood pressure \\> 180 mm Hg or diastolic blood pressure \\>105 mm Hg) with usual treatments (norepinephrine, ephedrine or phenylephrine for hypotension; intravenous nicardipine or uradipil for hypertension).","interventionNames":["Procedure: Standard blood pressure"]}],"interventions":[{"type":"PROCEDURE","name":"Individualized blood pressure","description":"Individualized blood pressure management during mechanical thrombectomy with the administration of diluted norepinephrine (5-10 µg/ml) or nicardipine (1 mg/ml) or urpidil (5 mg/ml) to maintain the MAP within 10% of the first MAP measured in the angiography suit","armGroupLabels":["Experimental group"]},{"type":"PROCEDURE","name":"Standard blood pressure","description":"Standard blood pressure management based on international guidelines: Treatment of hypotension defined by a systolic blood pressure \\<140 mm Hg, and treatment of hypertension defined by a systolic blood pressure \\> 180 mm Hg or diastolic blood pressure \\>105 mm Hg) with usual treatments (norepinephrine, ephedrine or phenylephrine for hypotension; intravenous nicardipine or uradipil for hypertension).","armGroupLabels":["Control group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of patient with a favorable functional outcome at 3 months","description":"Rankin score less than 3","timeFrame":"3 months visit"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\>18 years old\n* Acute ischemic stroke due to an anterior large vessel occlusion: occlusion of the M1 or M2 segments of the middle cerebral artery, anterior cerebral artery (A1 segment), intracranial internal carotid artery, or tandem occlusions.\n* Indication for mechanical thrombectomy under general anesthesia or conscious sedation within the first 6 hours from symptoms onset or within the first 24 hours if DAWN or DEFUSE-3 criteria are met.\n* Affiliation to social security assurance.\n\nExclusion Criteria:\n\n* Contre-indication to mechanical thrombectomy\n* Intubation or induction of general anaesthesia prior to randomization\n* Acute ischemic strokes associated with a posterior circulation large vessel occlusion (basilar artery, vertebral artery, posterior cerebral artery)\n* Intra-hospital onset of acute ischemic stroke, or secondary to a medical, interventional or surgical procedure (interventional cardiology, cardiac or vascular surgery) or any post-surgery ischemic stroke.\n* Pre-existing neurological disability limiting neurological assessment at 3 months: mRS \\>2 at randomization.\n* Contraindication to iodinated contrast agents\n* Known pregnancy or breastfeeding woman","healthyVolunteers":false,"sex":"ALL","genderBased":true,"genderDescription":"woman and man","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Amélie Yavchitz","role":"CONTACT","phone":"+33148036454","email":"ayavchitz@for.paris"}],"overallOfficials":[{"name":"Benjamin Dr Maier","affiliation":"Hopital Fondation A de Rothschild","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Etienne Dr Gayat","affiliation":"Hôpital Lariboisière, AP-HP","role":"STUDY_CHAIR"},{"name":"Morgan Dr Leguen","affiliation":"Hôpital Foch","role":"STUDY_CHAIR"},{"name":"Russel Dr Chabanne","affiliation":"CHU Gabriel Montpied","role":"STUDY_CHAIR"},{"name":"Baptiste Dr Balanca","affiliation":"Hospices Civils de Lyon, Hôpital Pierre Wertheimer","role":"STUDY_CHAIR"},{"name":"Benoit Pr Tavernier","affiliation":"Hôpital Roger Salengro, Lille","role":"STUDY_CHAIR"},{"name":"Thomas Pr Geeraerts","affiliation":"Hôpital Purpan, CHU Toulouse","role":"STUDY_CHAIR"},{"name":"Benjamin Pr Gory","affiliation":"\"Centre Hospitalier Régional Universitaire (Nancy)","role":"STUDY_CHAIR"},{"name":"Grégoire Dr Boulouis","affiliation":"Centre Hospitalier Régional Universitaire de Tours","role":"STUDY_CHAIR"},{"name":"Vincent Pr Degos","affiliation":"La Pitié Salpêtrière (APHP)","role":"STUDY_CHAIR"},{"name":"Gaultier Dr Marnat","affiliation":"CHU de Bordeaux, Hôpital Pellegrin","role":"STUDY_CHAIR"}],"locations":[{"facility":"Hôpital Fondation Adolphe de Rothschild","status":"RECRUITING","city":"Paris","country":"France","contacts":[{"name":"Amélie Yavchitz","role":"CONTACT"},{"name":"Benjamin Maier","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":48.85341,"lon":2.3488}}]},"referencesModule":{"references":[{"pmid":"35883180","type":"DERIVED","citation":"Maier B, Gory B, Chabanne R, Tavernier B, Balanca B, Audibert G, Thion LA, Le Guen M, Geeraerts T, Calviere L, Degos V, Lapergue B, Richard S, Djarallah A, Mophawe O, Boursin P, Le Cossec C, Blanc R, Piotin M, Mazighi M, Gayat E; DETERMINE Investigators. Effect of an individualized versus standard blood pressure management during mechanical thrombectomy for anterior ischemic stroke: the DETERMINE randomized controlled trial. Trials. 2022 Jul 26;23(1):598. doi: 10.1186/s13063-022-06538-9."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Acute Cerebrovascular Accident","relevance":"HIGH"},{"id":"M9762","name":"Hypotension","relevance":"LOW"},{"id":"M9714","name":"Hypertension","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M7656","name":"Ephedrine","relevance":"LOW"},{"id":"M27276","name":"Pseudoephedrine","relevance":"LOW"},{"id":"M13251","name":"Phenylephrine","relevance":"LOW"},{"id":"M12721","name":"Oxymetazoline","relevance":"LOW"},{"id":"M12265","name":"Norepinephrine","relevance":"LOW"},{"id":"M4544","name":"Benzocaine","relevance":"LOW"},{"id":"M12159","name":"Nicardipine","relevance":"LOW"},{"id":"T433","name":"Tannic Acid","relevance":"LOW"}],"browseBranches":[{"abbrev":"VaCoAg","name":"Vasoconstrictor Agents"},{"abbrev":"CNSSti","name":"Central Nervous System Stimulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Resp","name":"Respiratory System Agents"},{"abbrev":"CaAg","name":"Cardiotonic Agents"},{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"AnAg","name":"Antihypertensive Agents"},{"abbrev":"ChanBlk","name":"Channel Blockers"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"Ot","name":"Other Dietary Supplements"}]}},"hasResults":false}